February 18, 2025 · Form 4 insider transaction
Sulzberger Gabrielle bought 5.784 shares of Eli Lilly and Company at $857.20 per share, a transaction worth $5.0K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.